quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·423d
PRRelease
Singular Genomics Systems Inc. logo

Singular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBT

OMIC· Singular Genomics Systems Inc.
Industrials
Original source

Companies

  • OMIC
    Singular Genomics Systems Inc.
    Industrials

Recent analyst ratings

  • Aug 17UpdateUBS$4.50
  • Aug 10UpdateGoldman$3.50
  • Aug 10UpdateBofA Securities$3.00
  • Jan 7UpdateBofA Securities$21.00
  • Oct 15UpdateCowen-

Related

  • INSIDER420d
    Large owner Tang Kevin returned 372,000 shares to the company (SEC Form 4)
  • SEC420d
    Singular Genomics Systems Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Material Modification to Rights of Security Holders, Changes in Control of Registrant
  • SEC422d
    Amendment: SEC Form SCHEDULE 13D/A filed by Singular Genomics Systems Inc.
  • INSIDER422d
    Chief Executive Officer Spaventa Andrew returned 143,310 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER422d
    Chief Financial Officer Meeter Dalen returned 9,502 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER422d
    Chief Scientific Officer Glezer Eli N. returned 155,583 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER422d
    Chief Operating Officer Ghai Jyotsna returned 3,283 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER422d
    SEC Form 4 filed by Director Ryan Jason
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022